This category provides an overview of regulatory frameworks and industry standards applicable to different regulated manufacturing sectors. It addresses regulatory expectations for medical devices, pharmaceutical and biopharmaceutical manufacturing, compounding outsourcing facilities, and cosmetic product manufacturing.
Content in this category is intended to help readers understand how regulatory requirements differ by industry and how those requirements influence validation, qualification, and compliance activities across the product lifecycle.
Cosmetic product manufacturing is subject to regulatory oversight intended to protect consumer safety and product quality, even though cosmetics are not regulated as drugs or medical devices. In the United States and other major markets, manufacturers are expected to implement controls that ensure products are safe for their intended use and manufactured under appropriate conditions….
503B compounding pharmacies, also referred to as outsourcing facilities, occupy a unique regulatory position within the U.S. healthcare system. These facilities compound sterile and non-sterile drug products for distribution without patient-specific prescriptions and are therefore subject to heightened regulatory oversight. To ensure patient safety and product quality, 503B outsourcing facilities must comply with stringent requirements…
Regulatory validation requirements are central to maintaining control over biopharmaceutical manufacturing, where product quality cannot be assured by end testing alone. Biologics are inherently variable and sensitive to process conditions. As a result, regulators expect manufacturers to demonstrate, with documented evidence, that critical processes and systems consistently deliver products meeting requirements for safety, purity, potency,…
Title 21 of the Code of Federal Regulations, Part 211, commonly referred to as current Good Manufacturing Practice cGMP regulations, establishes the minimum requirements for the manufacture, processing, packing, and holding of drug products intended for human use in the United States. These regulations are issued and enforced by the U.S. Food and Drug Administration…
The Quality Management System Regulation (QMSR) is the current regulatory framework governing quality management system requirements for medical device manufacturers in the United States. Issued by the U.S. Food and Drug Administration, the QMSR replaces the former Quality System Regulation and harmonizes U.S. current good manufacturing practice requirements with ISO 13485:2016, the internationally recognized standard…
The Quality System Regulation QSR, established and enforced by the U.S. Food and Drug Administration, defines the mandatory quality system requirements for medical device manufacturers marketing products in the United States. QSR is codified in 21 CFR Part 820 and is legally binding for any organization that designs, manufactures, packages, labels, or services medical devices…
Quality System Regulation QSR — 21 CFR Part 820 21 CFR Part 820, commonly referred to as the Quality System Regulation QSR, establishes the regulatory baseline for the design, manufacture, packaging, labeling, storage, installation, and servicing of medical devices marketed in the United States. The regulation is issued and enforced by the U.S. Food and…
